[ORGANIZATION]
South Korean health authorities
Featured in 1 tracked story · first seen
Situations
South Korea GLP-1 obesity drug surge and illegal imports
3 clusters · 8 sources · last updated
Latest: South Korea sees 3.5x surge in illegal Wegovy and Mounjaro imports
Within ten months of their market launch in August 2023, GLP-1 obesity medicines—including Mounjaro and Wegovy—were prescribed more than 1.5 million times in South Korea. Monthly dispensing rose from under 2,000 prescrip